Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNUM.L Regulatory News (NUM)

  • There is currently no data for NUM

Trading Update

30 Mar 2020 07:00

RNS Number : 9488H
Numis Corporation PLC
30 March 2020
 

Numis Corporation Plc ("Numis")

Trading Update

 

 

Numis Corporation Plc ("Numis") is today issuing a trading update in respect of the six month period ending 31 March 2020.

Numis is expected to report revenue approximately 10% higher than the first half of the prior year. The six month trading period commenced during a period of elevated political uncertainty and ended with global markets suffering significant declines in reaction to the COVID-19 pandemic. The window available to execute transactions during the first half was therefore limited, resulting in subdued Investment Banking deal volumes for the period although this was partially offset by an increase in our average fee. As such, Investment Banking revenues are expected to be marginally below the comparable period.

Equities delivered a materially stronger performance, more than offsetting the Investment Banking revenue decline. Execution revenues benefited from an improvement in activity levels subsequent to the UK General Election; this has been sustained through the current market volatility experienced in recent weeks. In addition our trading book performance has been strong across the period delivering gains materially ahead of the prior period. 

Operationally we responded to COVID-19 promptly and successfully implemented comprehensive remote working capability which has enabled us to ensure both the safeguarding of our staff and the ability to continue servicing our clients across the business throughout this period of uncertainty.

We are working closely with our corporate clients to assess the impact of COVID-19, and the unprecedented disruption that many of them are currently experiencing. Whilst it is too early to predict the timing of a recovery in our Investment Banking pipeline, we are committed to supporting our corporate clients as they consider any actions they may implement to insulate and protect their businesses amid such uncertainty.

Numis benefits from a strong liquidity and capital position. Our cash balance is currently higher than the position reported at year end, in addition we have an undrawn, committed credit facility of £35m. We believe that now, more than ever, our balance sheet strength, market expertise and our long term partnership approach, ensure we are well positioned to provide broad support to our corporate and institutional clients during these unprecedented times.

Due to the ongoing COVID-19 situation and in view of recent regulatory communications regarding financial reporting, the announcement date of Numis' half year results for the six months ending 31 March 2020 will be confirmed in due course.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014

 

Contacts:

Numis Corporation:

Alex Ham & Ross Mitchinson, Co-Chief Executives 020 7260 1245

Andrew Holloway, Chief Financial Officer 020 7260 1266

 

Brunswick:

Nick Cosgrove 020 7404 5959

Simone Selzer 020 7404 5959

 

Grant Thornton UK LLP (Nominated Adviser):Philip Secrett 020 7728 2578

Harrison Clarke 020 7865 2411

Niall McDonald 020 7728 2347

 

 

Notes for Editors

Numis is a leading independent investment banking group offering a full range of research, execution, corporate broking and advisory services to companies and their investors. Numis is listed on AIM, and employs approximately 280 staff in London and New York.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKOBDBBKBKNB
Date   Source Headline
20th Mar 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Mar 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Mar 201811:06 amRNSTransaction in Own Shares and Total Voting Rights
12th Mar 20183:00 pmRNSDirectors' Dealing
9th Mar 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Mar 20184:00 pmRNSDirector's Dealing
23rd Feb 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Feb 20182:13 pmRNSHolding(s) in Company
15th Feb 201812:45 pmRNSHolding(s) in Company
13th Feb 20181:41 pmRNSHolding(s) in Company
13th Feb 201811:28 amRNSHolding(s) in Company
6th Feb 20181:17 pmRNSResult of AGM
6th Feb 20187:00 amRNSTrading update
5th Feb 201811:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Jan 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Jan 201812:00 pmRNSDirectors' Dealing
16th Jan 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Jan 201811:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Jan 20187:00 amRNSBoard Change
5th Jan 20189:14 amRNSTransaction in Own Shares and Total Voting Rights
3rd Jan 20187:00 amRNSAnnual Report and Annual General Meeting Notice
13th Dec 20173:00 pmRNSTransfer of Shares from Treasury to EBT and TVR
6th Dec 20177:00 amRNSPreliminary Results for the year ended 30 Sep 2017
29th Nov 20174:28 pmRNSTransaction in Own Shares and Total Voting Rights
21st Nov 201711:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Nov 201711:32 amRNSTransaction in Own Shares and Total Voting Rights
18th Oct 20173:00 pmRNSTransaction in Own Shares and Total Voting Rights
17th Oct 20173:00 pmRNSTransaction in Own Shares and Total Voting Rights
6th Oct 20177:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Oct 20177:32 amRNSTrading Update
29th Sep 20177:00 amRNSPurchase of Shares in Close Period
21st Sep 20177:00 amRNSCancellation of Share Premium Account
20th Sep 201711:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Sep 20173:00 pmRNSHolding(s) in Company
14th Sep 20177:00 amRNSDirector's Dealing
12th Sep 20173:00 pmRNSTransaction in Own Shares and Total Voting Rights
5th Sep 20174:32 pmRNSTransaction in Own Shares and Total Voting Rights
4th Sep 20174:34 pmRNSTransaction in Own Shares and Total Voting Rights
4th Sep 201711:09 amRNSHolding(s) in Company
1st Sep 20172:24 pmRNSHolding(s) in Company
1st Sep 20172:23 pmRNSDirector's Dealing
1st Sep 201712:26 pmRNSTransaction in Own Shares and Total Voting Rights
30th Aug 201711:00 amRNSResult of General Meeting
11th Aug 20171:00 pmRNSNotice of Meeting and Proposed Capital Reduction
9th Aug 20173:34 pmRNSTransaction in Own Shares and Total Voting Rights
7th Aug 20177:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Aug 20177:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Jul 20177:01 amRNSBoard Changes
28th Jul 20177:00 amRNSTrading Update
13th Jul 201711:00 amRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.